Company Quick10K Filing
Price28.24 EPS-1
Shares76 P/E-54
MCap2,146 P/FCF-1,087
Net Debt-176 EBIT-39
TEV1,970 TEV/EBIT-50
TTM 2019-10-31, in MM, except price, ratios
10-Q 2020-10-31 Filed 2020-12-04
10-Q 2020-07-31 Filed 2020-09-03
10-Q 2020-04-30 Filed 2020-06-05
10-K 2020-01-31 Filed 2020-03-19
10-Q 2019-10-31 Filed 2019-12-06
10-Q 2019-07-31 Filed 2019-09-06
10-Q 2019-04-30 Filed 2019-06-07
S-1 2019-03-15 Public Filing
8-K 2020-10-01
8-K 2020-09-20
8-K 2020-09-02
8-K 2020-06-22
8-K 2020-06-16
8-K 2020-06-04
8-K 2020-03-18
8-K 2019-12-11
8-K 2019-12-05
8-K 2019-09-18
8-K 2019-09-05
8-K 2019-06-06
8-K 2019-04-15

PD 10Q Quarterly Report

Part I - Financial Information
Part II - Other Information
Part I. Financial Information
Item 1. Financial Statements (Unaudited)
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
Part II. Other Information
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Securities and Use of Proceeds
Item 6. Exhibits
EX-31.1 pagerdutyq22020ex311.htm
EX-31.2 pagerdutyq22020ex312.htm
EX-32.1 pagerdutyq22020ex321.htm

PagerDuty Earnings 2020-07-31

Balance SheetIncome StatementCash Flow
Assets, Equity
Rev, G Profit, Net Income
Ops, Inv, Fin


(Mark One)
For the quarterly period ended July 31, 2020
For the transition period from                      to                     
Commission File Number: 001-38856
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification Number)
600 Townsend St., Suite 200
San Francisco, CA 94103
(844) 800-3889
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common Stock, $0.000005 par valuePDNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x No  o
Indicate by check mark whether the registrant has submitted electronically on its corporate Web site every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes     No  x
The total number of shares of common stock outstanding as of September 1, 2020, was 79,433,673.

Table of Contents
Item 1
Item 2
Item 3
Item 4
Item 1
Item 1A
Item 2
Item 6

Table of Contents
This Quarterly Report on Form 10-Q, or this Form 10-Q, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which statements involve substantial risk and uncertainties. All statements contained in this report other than statements of historical fact, including statements regarding our future operating results and financial position, our business strategy and plans, market growth and trends, and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “could,” “would,” “project,” “plan,” “potentially,” “likely,” and similar expressions are intended to identify forward-looking statements.
Forward-looking statement contained in this Form 10-Q include, but are not limited to, statements about our expectations regarding:
the effect of uncertainties related to the novel coronavirus and resulting COVID-19 pandemic on U.S. and global markets, our business, operations, revenue results, cash flow, operating expenses, demand for our solutions, sales cycles, customer retention, and our customers’ businesses;
trends in key business metrics, including number of customers and dollar-based net retention rate, and non-GAAP financial measures and their usefulness in evaluating our business;
trends in revenue, cost of revenue, and gross margin;
trends in operating expenses, including research and development, sales and marketing, and general and administrative expense, and expectations regarding these expenses as a percentage of revenue;
our existing cash and cash equivalents and cash provided by sales of our subscriptions being sufficient to support working capital and capital expenditures for at least the next 12 months;
our ability to service the interest on our convertible notes and repay such notes, to the extent required;
our efforts to maintain proper and effective internal controls;
our ability to expand our operations and increase adoption of our platform internationally;
our ability to stay abreast of new or modified laws and regulations that currently apply or become applicable to our business both in the United States and internationally;
the increased expenses and administrative workload associated with being a public company; and
other statements regarding our future operations, financial condition, and prospects and business strategies.
Such forward-looking statements are based on our expectations as of the date of this filing and are subject to a number of risks, uncertainties and assumptions, including but not limited to, risks detailed in the “Risk Factors” section of this Form 10-Q. Readers are urged to carefully review and consider the various disclosures made in this Form 10-Q and in other documents we file from time to time with the Securities and Exchange Commission, or the SEC, that disclose risks and uncertainties that may affect our business. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for us to predict all risks, nor can we assess the effect of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the future events and trends discussed in this Form 10-Q may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.
You should not rely on forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or may not occur. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future

Table of Contents
results, performance, or achievements. In addition, the forward-looking statements in this Form 10-Q are made as of the date of this filing, and we do not undertake, and expressly disclaim any duty, to update any of these forward-looking statements for any reason after the date of this Form 10-Q or to conform these statements to actual results or revised expectations.

Table of Contents
Item 1. Financial Statements (unaudited)
Condensed Consolidated Balance Sheets
(in thousands)
As of July 31, 2020As of January 31, 2020
Current assets:
Cash and cash equivalents$376,638 $124,024 
Accounts receivable, net of allowance for doubtful accounts of $1,712 and $810 as of July 31, 2020 and January 31, 2020, respectively
37,429 37,128 
Investments224,932 227,375 
Deferred contract costs, current10,326 9,301 
Prepaid expenses and other current assets11,950 7,163 
Total current assets661,275 404,991 
Property and equipment, net12,805 12,369 
Deferred contract costs, non-current16,497 16,387 
Lease right-of-use assets26,885  
Other assets1,725 1,651 
Total assets$719,187 $435,398 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$4,775 $6,434 
Accrued expenses and other current liabilities7,713 7,197 
Accrued compensation15,198 13,911 
Deferred revenue, current97,007 87,490 
Lease liabilities, current5,078  
Total current liabilities129,771 115,032 
Convertible senior notes, net210,976  
Deferred revenue, non-current4,173 5,079 
Lease liabilities, non-current29,064  
Other liabilities3,332 7,349 
Total liabilities377,316 127,460 
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common stock
Additional paid-in capital546,169 487,008 
Accumulated other comprehensive income1,056 137 
Accumulated deficit(205,354)(179,207)
Total stockholders’ equity341,871 307,938 
Total liabilities and stockholders’ equity
$719,187 $435,398 
See Notes to Condensed Consolidated Financial Statements

Table of Contents
Condensed Consolidated Statements of Operations and Comprehensive Loss
(in thousands, except per share data)
Three Months Ended July 31,Six Months Ended July 31,
Revenue$50,714 $40,361 $100,500 $77,675 
Cost of revenue6,637 6,106 13,600 11,592 
Gross profit44,077 34,255 86,900 66,083 
Operating expenses:
Research and development15,535 11,635 30,549 22,541 
Sales and marketing27,511 23,786 54,247 44,953 
General and administrative14,480 13,215 28,153 25,699 
Total operating expenses57,526 48,636 112,949 93,193 
Loss from operations(13,449)(14,381)(26,049)(27,110)
Interest income1,048 1,967 2,401 2,856 
Interest expense(1,608) (1,608) 
Other (expense) income, net(431)80 (412)101 
Loss before provision for income taxes(14,440)(12,334)(25,668)(24,153)
Provision for income taxes(248)(236)(479)(481)
Net loss$(14,688)$(12,570)$(26,147)$(24,634)
Other comprehensive income:
Unrealized gain on investments277  919  
Total comprehensive loss$(14,411)$(12,570)$(25,228)$(24,634)
Net loss per share, basic and diluted$(0.19)$(0.17)$(0.33)$(0.45)
Weighted average shares used in calculating net loss per share, basic and diluted
78,775 75,433 78,278 54,327 
See Notes to Condensed Consolidated Financial Statements

Table of Contents
Condensed Consolidated Statements of Stockholders’ Equity
(in thousands, except share data)
Three Months Ended July 31, 2020
Common StockAdditional
Accumulated Other Comprehensive IncomeAccumulated
Balances as of April 30, 202078,526,004 $ $497,430 $779 $(190,666)$307,543 
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases557,467  3,927   3,927 
Vesting of restricted stock units, net of employee payroll taxes
90,903  (1,697)  (1,697)
Vesting of early exercised options
  191   191 
Equity component of convertible senior notes, net of issuance costs
  68,478   68,478 
Purchases of capped calls related to convertible senior notes  (35,708)  (35,708)
Issuance of common stock in connection with employee stock purchase plan181,253  3,558   3,558 
Other comprehensive income
   277  277 
Stock-based compensation
  9,990   9,990 
Net loss
Balances as of July 31, 202079,355,627 $ $546,169 $1,056 $(205,354)$341,871 

Six Months Ended July 31, 2020
Common StockAdditional
Accumulated Other Comprehensive IncomeAccumulated
Balances as of January 31, 202077,793,540 $ $487,008 $137 $(179,207)$307,938 
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases1,286,892  5,771   5,771 
Vesting of restricted stock units, net of employee payroll taxes93,942  (1,743)  (1,743)
Vesting of early exercised options  507   507 
Equity component of convertible senior notes, net of issuance costs  68,478   68,478 
Purchases of capped calls related to convertible senior notes  (35,708)  (35,708)
Issuance of common stock in connection with employee stock purchase plan181,253  3,558   3,558 
Other comprehensive income   919  919 
Stock-based compensation  18,298   18,298 
Net loss    (26,147)(26,147)
Balances as of July 31, 202079,355,627 $ $546,169 $1,056 $(205,354)$341,871 


Table of Contents
Three Months Ended July 31, 2019
Common StockAdditional
Equity (Deficit)
Balances as of April 30, 201976,013,403 $ $454,559 $(140,932)$313,627 
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases
213,515  545  545 
Vesting of restricted stock units, net of employee payroll taxes
183  (10) (10)
Vesting of early exercised options
  338  338 
Stock-based compensation
  7,233  7,233 
Net loss
Balances as of July 31, 201976,227,101 $ $462,665 $(153,502)$309,163 

Six Months Ended July 31, 2019
Redeemable Convertible Preferred StockCommon StockAdditional Paid-in CapitalAccumulated DeficitTotal Stockholders’ Equity (Deficit)
Balances as of January 31, 201941,273,345 $173,023 23,189,921 $ $59,938 $(128,868)$(68,930)
Issuance of common stock upon exercise of stock options and restricted stock agreements, net of repurchases  1,165,345  2,785  2,785 
Vesting of restricted stock units, net of employee payroll taxes  183  (10) (10)
Exercise of common stock warrants  737,807     
Repayment of promissory note    515  515 
Issuance of common stock in connection with initial public offering, net of underwriting discounts and issuance costs  9,860,500  213,697  213,697 
Conversion of convertible preferred stock to common stock in connection with initial public offering(41,273,345)(173,023)41,273,345  173,023  173,023 
Vesting of early exercised options    672  672 
Stock-based compensation    12,045  12,045 
Net loss     (24,634)(24,634)
Balances as of July 31, 2019 $ 76,227,101 $ $462,665 $(153,502)$309,163 

Table of Contents
Condensed Consolidated Statements of Cash Flows
(in thousands)
Six Months Ended July 31,
Cash flows from operating activities
Net loss$(26,147)$(24,634)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization2,039 1,046 
Amortization of deferred contract costs5,064 3,442 
Amortization of debt discount and issuance costs1,258  
Stock-based compensation18,276 12,045 
Non-cash lease expense2,204  
Other1,426 83 
Changes in operating assets and liabilities:
Accounts receivable(1,293)(2,733)
Deferred contract costs(6,199)(6,690)
Prepaid expenses and other assets(4,989)(3,411)
Accounts payable(1,549)(2,712)
Accrued expenses and other liabilities3,618 2,433 
Accrued compensation1,287 2,031 
Deferred revenue8,611 13,693 
Lease liabilities(1,744) 
Net cash provided by (used in) operating activities1,862 (5,407)
Cash flows from investing activities
Purchases of property and equipment(3,292)(2,019)
Capitalization of internal-use software costs(111) 
Proceeds from maturities of held-to-maturity investments24,040  
Purchases of held-to-maturity investments (34,696)
Purchases of available-for-sale investments(100,029) 
Proceeds from maturities of available-for-sale investments71,632  
Proceeds from sales of available-for-sale investments7,285  
Net cash used in investing activities(475)(36,715)
Cash flows from financing activities
Proceeds from issuance of convertible senior notes, net of issuance costs paid of $8,151
Purchases of capped calls related to convertible senior notes
Proceeds from initial public offering, net of underwriters' discounts and commissions
Payments of costs related to initial public offering
Proceeds from employee stock purchase plan
Proceeds from repayment of promissory note
Proceeds from issuance of common stock upon exercise of stock options
5,771 2,785 
Employee payroll taxes paid related to net share settlement of restricted stock units
Net cash provided by financing activities251,227 218,168 
Net increase in cash, cash equivalents, and restricted cash252,614 176,046 
Cash, cash equivalents, and restricted cash at beginning of period124,024 130,323 
Cash, cash equivalents, and restricted cash at end of period$376,638 $306,369 
Supplemental cash flow data:
Cash paid for income taxes$ $56 
Non-cash investing and financing activities:
Vesting of early exercised options$507 $672 
Purchase of property and equipment, accrued but not yet paid
$385 $1,032 
Costs related to issuance of convertible senior notes, accrued but not yet paid$1,154 $ 
Costs related to initial public offering, accrued but not yet paid$ $737 
Non-cash purchases of property and equipment$ $2,364 
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets
Cash and cash equivalents$376,638 $306,316 
Restricted cash—included in other assets 53 
Total cash, cash equivalents, and restricted cash$376,638 $306,369 
See Notes to Condensed Consolidated Financial Statements

Table of Contents
Notes to Condensed Consolidated Financial Statements
1. Description of Business and Basis of Presentation
Description of Business
PagerDuty, Inc. was incorporated under the laws of the state of Delaware in May 2010.
PagerDuty acts as the central nervous system for the digital enterprise. PagerDuty harnesses digital signals from virtually any software-enabled system or device, combines it with human response data and orchestrates teams to take the right actions in real time. The Company’s products help organizations improve operations, accelerate innovation, increase revenue, mitigate security risk, and deliver a great customer experience.
As used herein, “PagerDuty”, “we”, “our”, “the Company” and similar terms include PagerDuty, Inc., unless the context indicates otherwise.
Initial Public Offering
On April 15, 2019, the Company completed its initial public offering (“IPO”), pursuant to which the Company issued and sold 9,860,500 shares of common stock, inclusive of the over-allotment option, at a public offering price of $24.00 per share. The Company received net proceeds of $213.7 million, after deducting underwriters' discounts and commissions of $16.6 million and other issuance costs of $6.4 million. Immediately prior to the closing of the Company’s IPO, all shares of the redeemable convertible preferred stock automatically converted into 41,273,345 shares of common stock.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated balance sheet as of January 31, 2020 was derived from the audited consolidated financial statements as of that date but does not include all of the information and notes required by GAAP for complete financial statements. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes thereto as of and for the year ended January 31, 2020, included in the Company’s Annual Report on Form 10-K, filed with the SEC.
The condensed consolidated financial statements include the results of PagerDuty, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.
In the opinion of management, the information contained herein reflects all adjustments necessary for a fair presentation of the Company’s results of operations, financial position, cash flows, and statements of stockholders’ equity. The results of operations for the three and six months ended July 31, 2020 are not necessarily indicative of the results to be expected for the full year ending January 31, 2021 or for any other interim period, or for any future year.
The Company’s fiscal year ends on January 31. References to fiscal 2021, for example, refer to the fiscal year ended January 31, 2021.
Convertible Senior Notes


Table of Contents 
Notes to Condensed Consolidated Financial Statements
In June 2020, The Company issued $287.5 million aggregate principal amount of 1.25% Convertible Senior Notes due 2025 (the “Notes”). See Note 8 for additional details.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make, on an ongoing basis, estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The Company’s most significant estimates and judgments involve the valuation of the Company’s stock-based awards, including the determination of fair value of common stock (prior to the closing of the IPO) and the fair value of the employee stock purchase plan (“ESPP”) expense, period of benefit for amortizing deferred contract costs, the determination of the allowance for doubtful accounts, the provision for income taxes, including the related valuation allowance and any uncertain tax positions, fair value of the liability and equity components of the Notes, and the incremental borrowing rate for lease liabilities, among others. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
In December 2019, the novel coronavirus and resulting disease (“COVID-19”) was reported and in March 2020 the World Health Organization declared it a pandemic. The extent of the impact of COVID-19 on our operational and financial performance will depend on certain developments, including the duration and spread of the outbreak, impact on our customers and our sales cycles, and impact on our employees, as discussed in more detail in the Overview section of our Management’s Discussion and Analysis. During the quarter, this uncertainty resulted in a higher level of judgment related to our estimates and assumptions related to the estimate of credit losses for accounts receivable. As of the date of issuance of the financial statements, we are not aware of any specific event or circumstance that would require us to update our estimates, judgments, or revise the carrying value of our assets or liabilities. These estimates may change as new events occur and additional information is obtained and are recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to our financial statements.

2. Summary of Significant Accounting Policies
Concentrations of Risk and Significant Customers
The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, held-to-maturity investments, available-for-sale investments, and accounts receivable. All of the Company’s cash and cash equivalents and investments are invested in money market funds, United States (“U.S.”) Treasury securities, commercial paper, corporate debt securities, or U.S. Government agency securities that management believes to be of high credit quality.
No single customer accounted for 10% of the total accounts receivable balance as of July 31, 2020 or January 31, 2020. No single customer represented 10% or more of revenue for the three and six months ended July 31, 2020 or 2019.
Segment Information
The Company manages operations and allocates resources as one operating segment. The Company’s chief operating decision maker (“CODM”) is its chief executive officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources. See Note 14, “Geographic Information” for information regarding the Company's long-lived assets and revenue by geography.
Significant Accounting Policies

Table of Contents 
Notes to Condensed Consolidated Financial Statements
There have been no significant changes to our significant accounting policies as compared to those described in our Annual Report on Form 10-K for the fiscal year ended January 31, 2020, other than as set forth below.
Convertible Senior Notes
The Notes are accounted for in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 470-20, Debt with Conversion and Other Options. Pursuant to ASC Subtopic 470-20, issuers of certain convertible debt instruments, such as the Notes, that have a net settlement feature and may be settled wholly or partially in cash upon conversion are required to separately account for the liability (debt) and equity (conversion option) components of the instrument. The carrying amount of the liability component of the instrument is computed by estimating the fair value of a similar liability without the conversion option using a market-based approach. The amount of the equity component is then calculated by deducting the fair value of the liability component from the principal amount of the instrument. The difference between the principal amount and the liability component represents a debt discount that is amortized to interest expense over the respective term of the Notes using the effective interest rate method. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. In accounting for the issuance costs related to the Notes, the allocation of issuance costs incurred between the liability and equity components was based on their relative values.
Accounts Receivable and Allowance for Doubtful Accounts
Accounts receivable are recorded at the invoiced amount, net of allowance for doubtful accounts. The allowance is based upon historical loss patterns, the age of each past due invoice, and an evaluation of the potential risk of loss associated with delinquent accounts. The allowance also reflects current market conditions and reasonable and supportable forecasts of future economic conditions. As of July 31, 2020, our allowance reflects considerations related to the COVID-19 pandemic and may increase in future periods as we ascertain future impacts to our customers and business. The allowance for doubtful accounts was $1.7 million and $0.8 million as of July 31, 2020 and January 31, 2020.
Recently Adopted Accounting Pronouncements
In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases, (“Topic 842”) (“ASU 2016-02”), which would require lessees to recognize most leases on their balance sheets, whether operating or financing, while continuing to recognize the expenses on their income statements in a manner similar to current practice. The guidance states that a lessee would recognize a lease liability for the obligation to make lease payments and a right-to-use asset for the right to use the underlying asset for the lease term. The Company adopted the standard using the optional alternative method on a prospective basis with an effective date as of the beginning of the Company’s fiscal year, February 1, 2020, and applied it to the operating leases that existed on that date. Prior year comparative financial information was not recast under the new standard and continues to be presented under ASC 840. The Company elected to utilize the package of practical expedients available for expired or existing contracts which allowed the Company to carryforward historical assessments of (a) whether contracts are or contain leases, (b) lease classification, and (c) initial direct costs. The Company elected to apply the short-term lease exception for all leases. Under the short-term lease exception, the Company will not recognize right-of-use assets or lease liabilities for leases that, at the acquisition date, have a remaining lease term of 12 months or less. As a result of implementing this guidance, the Company recognized a net operating right-of-use asset of $29.1 million and a $35.9 million operating lease liability in its condensed consolidated balance sheets as of February 1, 2020. The adoption of this guidance did not affect our condensed consolidated statements of operations or our condensed consolidated statements of cash flows. See Note 7, “Leases” for further information.
In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments—Credit Losses (“Topic 326”) Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which requires an entity to utilize a new impairment model known as the current expected credit loss (“CECL”) model to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. This guidance also requires new disclosures for financial assets measured at amortized cost, loans, and available-for-sale debt securities. The Company adopted the standard as of

Table of Contents 
Notes to Condensed Consolidated Financial Statements
the beginning of the Company’s fiscal year, February 1, 2020. The adoption of this guidance did not have a material impact to the condensed consolidated financial statements.
In August 2018, the FASB issued Accounting Standards Update No. 2018-13, Fair Value Measurement (“Topic 820”) (“ASU 2018-13”), which modifies the disclosure requirements for fair value measurements for certain types of investments. We adopted this standard in the first quarter of fiscal year 2020. The adoption did not have an effect on our consolidated financial statements.
In December 2019, the FASB issued Accounting Standards Update No. 2019-12, Income Taxes (“Topic 740”): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which is intends to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for the Company beginning in fiscal 2022, although early adoption is permitted. The Company early adopted the standard as of the beginning of the Company’s fiscal year, February 1, 2020. The adoption of this guidance did not have a material impact to the condensed consolidated financial statements.
Recently Issued Accounting Pronouncements
In August 2020, the FASB issued Accounting Standard Update No. 2020-06, Debt—Debt with Conversion Options (“Subtopic 470-20”) and Derivatives and Hedging—Contracts in Entity’s Own Equity (“Subtopic 815-40”) (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity's own equity. ASU 2020-06 also improves and amends the related Earnings Per Share guidance for both Subtopics. The ASU is part of the FASB's simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU 2020-06 will be effective for annual reporting periods beginning after December 15, 2021. Early adoption is permitted, but not before annual reporting periods beginning after December 15, 2020. We are currently evaluating the impact of the new guidance on our consolidated financial statements.

3. Cash, Cash Equivalents, and Investments
Cash, cash equivalents, and investments consisted of the following:

Table of Contents 
Notes to Condensed Consolidated Financial Statements
As of July 31, 2020As of January 31, 2020
(in thousands)
Cash and cash equivalents
$282,342 $2,131 
Money market funds
91,296 118,899 
U.S. Treasury securities
3,000 2,994 
Total cash and cash equivalents$376,638 $124,024 
Available-for-sale investments:
U.S. Treasury securities
$37,031 $24,987 
Commercial paper
22,011 20,132 
Corporate debt securities
161,887 149,248 
U.S. Government agency securities
Total available-for-sale investments$220,929 $199,340 
Held-to-maturity investments:
U.S. Treasury securities
$4,003 $9,016 
Commercial paper
Corporate debt securities
Total held-to-maturities investments$4,003 $28,035 
Total investments$224,932 $227,375 
The following tables summarize the Company’s investments’ adjusted cost, net unrealized gains, and fair value by significant investment category as of July 31, 2020 and January 31, 2020. Gross realized gains or losses from sales of available-for-sale securities were not material for the six months ended July 31, 2020.
As of July 31, 2020
Cost BasisUnrealized Gain, NetRecorded Basis
Available-for-sale investments:
U.S. Treasury securities $36,966 $65 $37,031 
Commercial paper22,008 3 22,011 
Corporate debt securities160,899 988 161,887 
Total available-for-sale investments$219,873 $1,056 $220,929 
Held-to-maturity investments:
U.S. Treasury securities $4,003 $ $4,003 
Total held-to-maturities investments$4,003 $ $4,003 
Total investments$223,876 $1,056 $224,932 

Table of Contents 
Notes to Condensed Consolidated Financial Statements
As of January 31, 2020
Cost BasisUnrealized Gain, NetRecorded Basis
Available-for-sale investments:
U.S. Treasury securities $24,978 $9 $24,987